2016
DOI: 10.1016/j.biocel.2016.02.004
|View full text |Cite
|
Sign up to set email alerts
|

TLR-7 agonist attenuates airway reactivity and inflammation through Nrf2-mediated antioxidant protection in a murine model of allergic asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
24
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(24 citation statements)
references
References 48 publications
0
24
0
Order By: Relevance
“…Nuclear factor erythroid 2-related factor 2 (Nrf2) is involved in a classical antioxidant pathway. When Nrf2 gene dysfunction occurs, animal models are prone to asthma induction or asthma aggravation, and a large number of neutrophils aggregate, resulting in airway inflammation, AHR and airway remodeling [33,34]. At the same time, the use of an Nrf2 activator or an antioxidant stress treatment can improve symptoms, which confirms the importance of oxidative stress in neutrophilic asthma [35].…”
Section: Oxidative Stressmentioning
confidence: 90%
“…Nuclear factor erythroid 2-related factor 2 (Nrf2) is involved in a classical antioxidant pathway. When Nrf2 gene dysfunction occurs, animal models are prone to asthma induction or asthma aggravation, and a large number of neutrophils aggregate, resulting in airway inflammation, AHR and airway remodeling [33,34]. At the same time, the use of an Nrf2 activator or an antioxidant stress treatment can improve symptoms, which confirms the importance of oxidative stress in neutrophilic asthma [35].…”
Section: Oxidative Stressmentioning
confidence: 90%
“… 38 TLR-7 activation was shown to result in Nrf2-mediated antioxidant protection against ROS through myeloid differentiation primary response gene 88, a TLR adaptor protein that activates NF- Îș B. 39 …”
Section: Discussionmentioning
confidence: 99%
“…Proinflammatory effects have been described for Tlrs previously (34), whereas other studies implied protective effects of activated Tlr2, Tlr7 and Tlr8 in mouse models of asthma (35,36,40). Treatment with Tlr7/8 agonist, resiquimod (RSQ), was reported to reduce allergen-induced airway reactivity and inflammation (35). The underlying mechanism is associated with the induction of NF-E2-related factor 2 and copper/zinc superoxide dismutase (35).…”
Section: Discussionmentioning
confidence: 85%
“…Treatment with Tlr7/8 agonist, resiquimod (RSQ), was reported to reduce allergen-induced airway reactivity and inflammation (35). The underlying mechanism is associated with the induction of NF-E2-related factor 2 and copper/zinc superoxide dismutase (35). The suppressive effect of RSQ in asthma is further dependent on the induction of IL-27 and is associated with enhanced expression of the immunomodulatory molecule B7-homolog 1 on pulmonary antigen presenting cells (36).…”
Section: Discussionmentioning
confidence: 99%